Skip to main content
. 2015 Oct 8;4(10):595–604. doi: 10.1002/psp4.12031

Table 1.

Model parameter estimates using the ocular-serum TMDD model

Parameter Symbol (unit) Estimate RSE (%) 95% CI Shrinkage (%)
Lower Upper
Ocular parameters
Ocular elimination rate constant of druga kout (1/day) 0.117 1.25 0.111 0.123
Ocular elimination rate constant of complex koutC (1/day) 0.135 1.54 0.127 0.144
Ocular influx/synthesis rate constant of target kinT (µg/mL/day) 0.364 0.635 0.360 0.369
Correction factor for drug:target molar ratio and assay differencesc λA 2.23 27.7 1.440 3.46
Vitreous volume of distribution VVITR (mL) 3.09 3.24 2.88 3.23
Ocular degradation/elimination rate constant of drug target koutT (1/day) 0.27 0.935 0.236 0.276
Vitreous-aqueous partition coefficient of drug λAQ 13.0 0.586 12.7 13.4
Systemic parameters
Systemic volume of distribution Vc (mL) 2410 0.0658 2390 2440
Systemic elimination rate constant of druga k (1/day) 1.89 6.53 1.74 2.05
Quasi-steady rate constantd Kss (µg/mL) 0.96 × 10−3 (fixed)
Covariates
Power for age effect on kout Θage-kout −0.770 45.5 −1.45 −0.0831
Power for age effect on k Θage-k −1.63 23.5 −2.38 −0.877
Multiplier for sex effect on k Θsex-k 0.739 21.1 0.652 0.837
Variability
Intersubject variability for ocular clearance Inline graphic 27.3% 19.1b 21.6% 32.0% 6.3
Intersubject variability for correction factor ω2λA 59.1% 38.0b 29.8% 78.0% 0.8
Intersubject variability for systemic clearance Inline graphic 27.5% 23.8b 20.1% 33.3% 20.7
Residual error for aqueous measurements Inline graphic, AQ 25.8% 28.3b 17.2% 32.2%
Residual error for serum measurement Inline graphic, SER 32.9% 10.1b 29.5% 36.1%

CI, confidence interval; RSE, relative standard error.

a

For a typical 80-year-old male patient.

b

RSE for variances.

c

Ratio of the molecular weights of the drug and the target is equal to 2 (within 95% CI of the estimated value). Minor difference with the estimated value could be due to assay differences or differences in volumes of distributions of the drug and the target.

d

Fixed to 20 pM, approximately equal to in vitro KD value (19.7 pM), as the estimated elimination rate of the drug-target complex (koutC) is much smaller than dissociation rate of the drug-target complex.8,11